OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Capital Raises

Equity Capital Raises

Equity Transaction Chart

Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.

Week ended 06/23/2023

Week ended 06/23/2023

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Equity Commentary

Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.

Week ended 06/23/2023

The Week’s Largest Equity Transaction:

  • On June 23, 2023, TerrAscend Corp. (TER: CSE)(TRSSF: OTCQX), The sixth-largest U.S. MSO by market cap, closed a $6.1M private placement of equity units.
  • 07M units were sold at $1.50 per unit.
  • Each unit consists of one common share and ½ of a warrant with a two-year life and an exercise price of $1.95.
  • The warrants are worth approximately $.08 per unit producing a net share price of $1.424, a 24.65% discount from the pre-announcement price.
  • Interestingly, the total size of the initial tranches of the combined equity and concurrent debt issues was increased by approximately $1M since the deal was announced (with an additional $4M to close on June 28). The initial equity portion was reduced by $.76M, while the debt was increased by $2.41M. Insiders purchased 0.6% of the equity and 20.2% of the debt.
  • The transaction implies an EV/2023 revenue multiple of 2.49x and an EV/2023 EBITDA multiple of 11.78X, considerable premiums to the 1.27x and 5.93x medians and 1.5x and 7.74x third quartile measures of the 19 analyst-covered MSOs with market caps over $20M in the Viridian Capital Value Tracker.
  • We believe a considerable amount of this premium relates to the company’s plan to up-list to the TSX, which should increase the trading liquidity of its stock. Historically, part of TER’s premium may have also come from its association and implied support by Canopy/Constellation. The value of this support has declined as Canopy has become less financially healthy. TER’s recent purchase of a Maryland dispensary and its positioning in New Jersey both support some premium, but it seems like most of this is already baked into the stock.

Public vs. Private Raises: 

  • TerrAscend (TER: CSE)(TRSSF: OTCQX) was the only public company that raised capital this week.

Equity vs. Debt Cap Raises: 

  • Equity accounted for two capital raises this week and 74.7% of the funds raised.

Week ended 06/23/2023

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

Weekly Valuation Tracker

Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector.  The Weekly Valuation Tracker provides proprietary, actionable valuation data.

This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.   

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.